Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case–control study’
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case–control study’
Winkler, M. S.; Korsten, P.; Binder, C. & Tampe, B. (2020)
Annals of the Rheumatic Diseases, pp. annrheumdis-2020-218836. DOI: https://doi.org/10.1136/annrheumdis-2020-218836
